AVXL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.00%

Insider Buying (Last 12 Months): $32,919.40

Insider Selling (Last 12 Months): $374,971.80

Anavex Life Sciences Insider Trading History Chart

Anavex Life Sciences Share Price & Price History

^$6.84

▲ +0.21 (3.17%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Sell NVDA Now?

From Chaikin Analytics | Ad

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).

Anavex Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2024	Peter D.O. Donhauser	Director	Buy	2,835	$3.64	$10,319.40	5,000
5/15/2024	Steffen Thomas	Director	Buy	5,000	$4.52	$22,600.00	5,000
3/28/2024	Christopher U Missling	CEO	Sell	73,380	$5.11	$374,971.80	1,250,210
6/28/2023	Christopher U Missling	CEO	Sell	268,000	$7.98	$2,138,640.00	1,018,210
5/25/2022	Athanasios Skarpelos	Director	Sell	50,000	$9.06	$453,000.00	1,306,458

True paradigm shift

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Anavex Life Sciences (NASDAQ:AVXL)

31.55% of Anavex Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Anavex Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/1/2024	Atria Investments Inc	13,300	$76K	0.0%	N/A	0.016%
10/30/2024	Balentine LLC	20,200	$0.12M	0.0%	N/A	0.024%
10/29/2024	Forum Financial Management LP	35,140	$0.20M	0.0%	N/A	0.042%
10/25/2024	China Universal Asset Management Co. Ltd.	16,309	$93K	0.0%	+64.0%	0.019%
10/22/2024	Private Advisor Group LLC	47,413	$0.27M	0.0%	+10.3%	0.056%
10/11/2024	Creative Planning	39,871	$0.23M	0.0%	+54.2%	0.047%
10/3/2024	SG Americas Securities LLC	27,706	$0.16M	0.0%	+106.2%	0.033%
8/15/2024	The Manufacturers Life Insurance Company	30,510	$0.13M	0.0%	+8.5%	0.036%
8/15/2024	Deerfield Management Company L.P. Series C	81,890	$0.35M	0.0%	N/A	0.097%
8/15/2024	AQR Capital Management LLC	45,219	$0.19M	0.0%	+145.8%	0.053%
8/14/2024	Squarepoint Ops LLC	45,352	$0.19M	0.0%	N/A	0.054%
8/14/2024	Marshall Wace LLP	39,351	$0.17M	0.0%	N/A	0.046%
8/14/2024	ProShare Advisors LLC	14,905	$63K	0.0%	-20.5%	0.018%
8/14/2024	Profund Advisors LLC	41,280	$0.17M	0.0%	-59.9%	0.049%
8/12/2024	E Fund Management Co. Ltd.	13,623	$57K	0.0%	-57.0%	0.016%
8/9/2024	Renaissance Technologies LLC	466,437	$1.97M	0.0%	+483.8%	0.551%
8/6/2024	Los Angeles Capital Management LLC	22,077	$93K	0.0%	-74.9%	0.026%
8/1/2024	Rhumbline Advisers	119,289	$0.50M	0.0%	+15.8%	0.141%
7/29/2024	Principal Financial Group Inc.	11,408	$48K	0.0%	-46.4%	0.013%
7/26/2024	Bank of New York Mellon Corp	280,556	$1.18M	0.0%	+17.1%	0.331%
7/12/2024	SG Americas Securities LLC	13,434	$57K	0.0%	N/A	0.016%
7/10/2024	Fiduciary Alliance LLC	19,275	$80K	0.0%	+45.2%	0.023%
5/20/2024	Virtu Financial LLC	40,612	$0.21M	0.0%	+87.5%	0.048%
5/16/2024	California State Teachers Retirement System	81,052	$0.41M	0.0%	-4.5%	0.096%
5/14/2024	Sheaff Brock Investment Advisors LLC	17,750	$90K	0.0%	-52.3%	0.021%
5/14/2024	EntryPoint Capital LLC	20,007	$0.10M	0.1%	+371.1%	0.024%
5/10/2024	Vanguard Group Inc.	4,414,682	$22.47M	0.0%	+1.2%	5.376%
5/10/2024	Jupiter Asset Management Ltd.	804,642	$4.10M	0.0%	+675.0%	0.980%
5/10/2024	Nwam LLC	836,730	$4.26M	0.3%	+4.8%	1.019%
5/4/2024	Geneos Wealth Management Inc.	74,400	$0.38M	0.0%	+10.1%	0.091%
5/1/2024	BNP Paribas Financial Markets	46,527	$0.24M	0.0%	-58.1%	0.057%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	54,850	$0.28M	0.0%	+30.2%	0.067%
4/29/2024	China Universal Asset Management Co. Ltd.	15,773	$80K	0.0%	+66.1%	0.019%
4/18/2024	Saxon Interests Inc.	26,699	$0.14M	0.1%	N/A	0.033%
4/17/2024	Fiduciary Alliance LLC	13,275	$67K	0.0%	N/A	0.016%
4/5/2024	Los Angeles Capital Management LLC	87,931	$0.45M	0.0%	+51.4%	0.107%
2/26/2024	Virtu Financial LLC	21,658	$0.20M	0.0%	N/A	0.026%
2/13/2024	Tower Research Capital LLC TRC	10,637	$99K	0.0%	+32.3%	0.013%
2/13/2024	Belpointe Asset Management LLC	10,000	$93K	0.0%	N/A	0.012%
2/13/2024	Rafferty Asset Management LLC	232,031	$2.16M	0.0%	-14.3%	0.283%
2/9/2024	Trexquant Investment LP	57,655	$0.54M	0.0%	N/A	0.070%
2/9/2024	D.A. Davidson & CO.	11,250	$0.11M	0.0%	N/A	0.014%
2/8/2024	Sheaff Brock Investment Advisors LLC	37,250	$0.35M	0.0%	+71.3%	0.045%
2/8/2024	Independent Advisor Alliance	47,644	$0.44M	0.0%	+10.4%	0.058%
2/8/2024	Hayek Kallen Investment Management	10,673	$99K	0.0%	N/A	0.013%
2/7/2024	Jump Financial LLC	60,986	$0.57M	0.0%	-19.1%	0.074%
2/7/2024	BNP Paribas Financial Markets	111,032	$1.03M	0.0%	+34.2%	0.135%
2/7/2024	Teacher Retirement System of Texas	18,908	$0.18M	0.0%	-17.3%	0.023%
2/6/2024	Charles Schwab Investment Management Inc.	622,310	$5.79M	0.0%	+2.9%	0.758%
2/6/2024	Private Advisor Group LLC	40,980	$0.38M	0.0%	-4.3%	0.050%
2/6/2024	Los Angeles Capital Management LLC	58,087	$0.54M	0.0%	+187.3%	0.071%
2/6/2024	Swiss National Bank	161,500	$1.50M	0.0%	-9.1%	0.197%
2/5/2024	Victory Capital Management Inc.	10,717	$100K	0.0%	N/A	0.013%
2/1/2024	New York State Common Retirement Fund	29,321	$0.27M	0.0%	+10.0%	0.036%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	20,671	$0.19M	0.0%	+54.6%	0.025%
1/30/2024	Carnegie Capital Asset Management LLC	73,660	$0.69M	0.0%	+9.3%	0.090%
1/26/2024	Geneos Wealth Management Inc.	67,600	$0.63M	0.0%	+60.6%	0.082%
1/24/2024	China Universal Asset Management Co. Ltd.	9,498	$88K	0.0%	+351.6%	0.012%
1/19/2024	Foster Victor Wealth Advisors LLC	35,663	$0.33M	0.0%	+15.9%	0.043%
1/12/2024	Premier Path Wealth Partners LLC	12,500	$0.12M	0.0%	N/A	0.015%
1/12/2024	SG Americas Securities LLC	307,568	$2.86M	0.0%	+14.2%	0.375%
12/18/2023	Vanguard Group Inc.	4,245,344	$27.81M	0.0%	+1.0%	5.172%
12/6/2023	Citigroup Inc.	118,446	$0.78M	0.0%	-4.5%	0.144%
11/27/2023	AllSquare Wealth Management LLC	54,956	$0.36M	0.2%	-15.4%	0.067%
11/16/2023	Orion Capital Management LLC	9,000	$59K	0.0%	N/A	0.011%
11/14/2023	Profund Advisors LLC	45,965	$0.30M	0.0%	-27.8%	0.056%
11/13/2023	Dark Forest Capital Management LP	11,530	$76K	0.0%	N/A	0.014%
11/13/2023	Rafferty Asset Management LLC	270,788	$1.77M	0.0%	-22.8%	0.330%
11/13/2023	E Fund Management Co. Ltd.	13,908	$91K	0.0%	-26.2%	0.017%
11/9/2023	Citigroup Inc.	118,446	$0.78M	0.0%	-4.5%	0.145%
11/9/2023	Blair William & Co. IL	12,200	$80K	0.0%	N/A	0.015%
11/8/2023	Charles Schwab Investment Management Inc.	604,811	$3.96M	0.0%	+4.1%	0.738%
11/8/2023	Swiss National Bank	177,700	$1.16M	0.0%	+2.5%	0.217%
11/7/2023	Barclays PLC	160,577	$1.05M	0.0%	-16.4%	0.196%
11/7/2023	Jump Financial LLC	75,392	$0.49M	0.0%	+360.6%	0.092%
11/6/2023	Los Angeles Capital Management LLC	20,220	$0.13M	0.0%	N/A	0.025%
11/3/2023	Private Advisor Group LLC	42,830	$0.28M	0.0%	+35.2%	0.052%
11/1/2023	Nwam LLC	720,990	$4.72M	0.5%	+13.6%	0.880%
10/27/2023	Hennion & Walsh Asset Management Inc.	59,550	$0.39M	0.0%	-16.5%	0.073%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	42,805	$0.28M	0.0%	-6.9%	0.052%
10/25/2023	BNC Wealth Management LLC	16,600	$0.11M	0.1%	+27.2%	0.020%
10/24/2023	Independent Advisor Alliance	43,144	$0.28M	0.0%	+54.6%	0.053%
10/24/2023	Raymond James Financial Services Advisors Inc.	31,155	$0.20M	0.0%	-6.5%	0.038%
10/24/2023	Cambridge Investment Research Advisors Inc.	16,275	$0.11M	0.0%	N/A	0.020%
10/23/2023	Commonwealth Equity Services LLC	83,233	$0.55M	0.0%	-5.4%	0.102%
10/13/2023	SG Americas Securities LLC	269,413	$1.77M	0.0%	N/A	0.329%
9/12/2023	Prosperity Financial Group Inc.	23,897	$0.19M	0.2%	-50.2%	0.029%
8/11/2023	Natixis	8,000	$65K	0.0%	N/A	0.010%
8/11/2023	E Fund Management Co. Ltd.	18,853	$0.15M	0.0%	-28.6%	0.023%
8/11/2023	ExodusPoint Capital Management LP	76,029	$0.62M	0.0%	-21.3%	0.094%
8/10/2023	Profund Advisors LLC	63,654	$0.52M	0.0%	-25.9%	0.079%
8/10/2023	Private Advisor Group LLC	31,680	$0.26M	0.0%	-19.1%	0.039%
8/10/2023	Nwam LLC	634,600	$5.16M	0.4%	+15.8%	0.785%
8/10/2023	Cetera Advisor Networks LLC	83,678	$0.68M	0.0%	+6.1%	0.104%
8/9/2023	BNP Paribas Arbitrage SNC	71,296	$0.58M	0.0%	-58.3%	0.088%
8/9/2023	Lido Advisors LLC	12,100	$98K	0.0%	N/A	0.015%
8/7/2023	Principal Financial Group Inc.	20,955	$0.17M	0.0%	+8.8%	0.026%
8/4/2023	Saturna Capital CORP	12,540	$0.10M	0.0%	-30.1%	0.016%
8/4/2023	Carnegie Capital Asset Management LLC	68,060	$0.55M	0.0%	+55.8%	0.084%
8/4/2023	Liberty One Investment Management LLC	15,826	$0.13M	0.0%	+22.4%	0.020%

Data available starting January 2016

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Today's Range

Now: $6.84

$6.50

$7.07

50 Day Range

MA: $5.58

$5.01

$6.84

52 Week Range

Now: $6.84

$3.25

$10.45

Volume

2,000,680 shs

Average Volume

1,159,568 shs

Market Capitalization

$579.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Anavex Life Sciences?: Anavex Life Sciences' top insider shareholders include:
Christopher U Missling (CEO)
Peter DO Donhauser (Director)
Steffen Thomas (Director)
Learn More about top insider investors at Anavex Life Sciences.
Who are the major institutional investors of Anavex Life Sciences?: Anavex Life Sciences' top institutional shareholders include:
Private Advisor Group LLC — 0.06%
Creative Planning — 0.05%
Forum Financial Management LP — 0.04%
SG Americas Securities LLC — 0.03%
Balentine LLC — 0.02%
China Universal Asset Management Co. Ltd. — 0.02%
Learn More about top institutional investors of Anavex Life Sciences stock.
Which major investors are buying Anavex Life Sciences stock?: During the last quarter, AVXL stock was acquired by institutional investors including:
Forum Financial Management LP
Balentine LLC
SG Americas Securities LLC
Creative Planning
Atria Investments Inc
China Universal Asset Management Co. Ltd.
Private Advisor Group LLC
During the previous year, these company insiders have bought Anavex Life Sciences stock:
Christopher U Missling (CEO)
Peter DO Donhauser (Director)
Learn More investors buying Anavex Life Sciences stock.